PACT Pharma private stock trade

PACT Pharma

Legal NamePACT Pharma, Inc.
HeadquartersHayward, CA
SectorBioTech

PACT Pharma is a biotechnology company specializing in the development of personalized cancer therapies. The company's primary focus is on creating individualized immunotherapies for cancer patients, leveraging the patient's own immune system to target and fight cancer cells effectively. PACT Pharma's approach involves sequencing a patient's tumor DNA and designing customized T-cell therapies to target the specific mutations found in the cancer.

Learn more about PACT Pharma IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
--ZX Index Value MoM Change
--ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for PACT Pharma, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for PACT Pharma, log in to ZXData or contact us to request access.
View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.